KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) EBIT Margin: 2015-2025

Historic EBIT Margin for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to 21.49%.

  • Medpace Holdings' EBIT Margin rose 44.00% to 21.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.50%, marking a year-over-year increase of 176.00%. This contributed to the annual value of 21.19% for FY2024, which is 333.00% up from last year.
  • As of Q3 2025, Medpace Holdings' EBIT Margin stood at 21.49%, which was up 2.62% from 20.94% recorded in Q2 2025.
  • Medpace Holdings' EBIT Margin's 5-year high stood at 23.37% during Q4 2024, with a 5-year trough of 15.25% in Q2 2021.
  • Its 3-year average for EBIT Margin is 19.92%, with a median of 20.32% in 2025.
  • In the last 5 years, Medpace Holdings' EBIT Margin crashed by 340bps in 2021 and then soared by 585bps in 2024.
  • Quarterly analysis of 5 years shows Medpace Holdings' EBIT Margin stood at 17.78% in 2021, then spiked by 162bps to 19.39% in 2022, then tumbled by 187bps to 17.52% in 2023, then skyrocketed by 585bps to 23.37% in 2024, then spiked by 44bps to 21.49% in 2025.
  • Its EBIT Margin was 21.49% in Q3 2025, compared to 20.94% in Q2 2025 and 20.32% in Q1 2025.